1. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14. PMID:
23613665.
2. Van der Horst PH, Wang Y, Vandenput I, Kuhne LC, Ewing PC, van Ijcken WF, et al. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer. PLoS One 2012;7:e30840PMID:
22295114.
3. Gadducci A, Cosio S, Genazzani AR. Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer. Crit Rev Oncol Hematol 2011;80:181-192. PMID:
21134766.
4. Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, et al. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 2004;64:2192-2198. PMID:
15026362.
5. Maletzki C, Bodammer P, Breitruck A, Kerkhoff C. S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma. Hepat Mon 2012;12(10 HCC):e7240PMID:
23166536.
6. Stojanovic A, Cerwenka A. Natural killer cells and solid tumors. J Innate Immun 2011;3:355-364. PMID:
21502747.
7. Tavassoli FA, Devilee P. International Agency for Research on Cancer. World Health Organization. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press; 2003.
8. Honig A, Schaller N, Dietl J, Backe J, Kammerer U. S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma. Anticancer Res 2005;25:1747-1753. PMID:
16033094.
9. Coppola D, Fu L, Nicosia SV, Kounelis S, Jones M. Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Hum Pathol 1998;29:455-462. PMID:
9596268.
10. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol 2004;25:242-248. PMID:
15099564.
11. Wallace AE, Gibson DA, Saunders PT, Jabbour HN. Inflammatory events in endometrial adenocarcinoma. J Endocrinol 2010;206:141-157. PMID:
20406782.
12. Kara PP, Ayhan A, Caner B, Gultekin M, Ugur O, Bozkurt MF, et al. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers. Int J Gynecol Cancer 2009;19:1239-1243. PMID:
19823061.
13. Oka K, Nakano T, Arai T. Adenocarcinoma of the cervix treated with radiation alone: prognostic significance of S-100 protein and vimentin immunostaining. Obstet Gynecol 1992;79:347-350. PMID:
1738512.
14. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 2007;5:62PMID:
18047662.
15. Elagoz S, Arici DS, Aker H. Relationship between FIGO grade and AgNOR, S100-positive langerhans cells in endometrial adenocarcinoma. Pathol Int 2000;50:616-619. PMID:
10972859.
16. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B. Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 1996;28:321-327. PMID:
9007950.
17. Karakok M, Bayazit YA, Ucak R, Ozer E, Kanlikama M, Mumbuc S, et al. Langerhans cell related inflammatory reaction in laryngeal squamous cell carcinoma. Auris Nasus Larynx 2003;30:81-84. PMID:
12589856.
18. Liska V, Vycital O, Daum O, Novak P, Treska V, Bruha J, et al. Infiltration of colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prognostic factors after radical surgical treatment. Anticancer Res 2012;32:2129-2132. PMID:
22593500.
19. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997;150:641-651. PMID:
9033277.
20. De Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, et al. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol 2009;114:105-110. PMID:
19411095.
21. Lijun Z, Xin Z, Danhua S, Xiaoping L, Jianliu W, Huilan W, et al. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma. Int J Gynecol Cancer 2012;22:836-841. PMID:
22617481.
22. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 1995;154:3821-3835. PMID:
7706722.